ChromaJean

ChromaJean is a Japanese biotechnology company specializing in the automation and standardization of chromatography processes for drug discovery and development. Spun off from Takeda Pharmaceutical's Entrepreneurship Venture Program in 2017, the company provides proprietary algorithms and automated platforms, such as Jeanious One LC and Jeanious One FC, to streamline the purification of small molecules, peptides, and oligonucleotides. By reducing the reliance on expert intuition and manual labor, ChromaJean's technology enables pharmaceutical researchers to accelerate their lead optimization cycles and improve productivity. The company operates out of the Shonan Health Innovation Park and collaborates with major industry players like PeptiDream and Kissei Pharmaceutical.